Related Experiment Video
Updated: Oct 29, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study
Jiang Yue1, Hua Xu1, Yong Zhou2
1Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Insights
Lipid metabolic disorders are present in critical COVID-19 patients. Lower high-density lipoprotein cholesterol (HDL-c) and total cholesterol (TC) levels are linked to disease progression and mortality in these patients.
Area of Science:
- Biochemistry
- Infectious Diseases
- Critical Care Medicine
Background:
- Dyslipidemia has been linked to coronavirus-related diseases.
- Critical coronavirus disease 2019 (COVID-19) patients with multiple organ dysfunctions were admitted to the ICU.
- The association between lipid profiles and prognosis in critical COVID-19 patients was unclear.
Purpose of the Study:
- To investigate the association between lipid profiles and prognosis in critical COVID-19 patients.
- To identify potential lipid biomarkers for COVID-19 severity.
Main Methods:
- A retrospective study of 48 critical COVID-19 patients in Wuhan.
- Collected lipid profiles, liver function, and renal function parameters on admission, at 2-3 days post-admission, and before clinical outcome.
- Utilized logistic regression to analyze associations with mortality.
Main Results:
- Albumin and creatine kinase levels decreased significantly post-admission.
- Low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), apolipoprotein A (ApoA), and apolipoprotein B (ApoB) levels decreased after admission.
- Lower HDL-c levels on admission and before outcome were negatively associated with mortality.
- Total cholesterol (TC) levels at 2-3 days post-admission were related to mortality.
Conclusions:
- Critical COVID-19 patients exhibit lipid metabolic disorders.
- Lower HDL-c and TC levels correlate with disease progression and mortality in critical COVID-19.
- Lipid profiles may serve as prognostic indicators for critical COVID-19 patients.
Background:
It has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associated with the prognosis of COVID-19 in critical patients remained unclear.
Methods:
A retrospective study was performed in critical patients (N=48) with coronavirus disease 2019 in Leishenshan hospital between February and April 2020 in Wuhan. The parameters including lipid profiles, liver function, and renal function were collected on admission day, 2-3days after the admission, and the day before the achievement of clinical outcome.
Results:
Albumin value and creatine kinase (ck) value were statistically decreased at 2-3 days after admission compared with those on admission day (P<0.05). Low density lipoprotein (LDL-c), high density lipoprotein (HDL-c), apolipoprotein A (ApoA), and apolipoprotein A (Apo B) levels were statistically decreased after admission (P<0.05). Logistic regression showed that HDL-c level both on admission day and the day before the achievement of clinical outcome were negatively associated with mortality in critical patients with COVID-19. Total cholesterol (TC) level at 2-3days after admission was related to mortality in critical patients with COVID-19.
Conclusions:
There were lipid metabolic disorders in the critical patients with COVID-19. Lower levels of HDL-c and TC were related to the progression of critical COVID-19.
More Related Videos
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements

